Target intelligence / Profile preview

Probable G protein-coupled receptor 33 (GPR33)

Target
GPR33
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Probable G protein-coupled receptor 33 (GPR33) is a member of the rhodopsin-like (class A) G protein-coupled receptor (GPCR) superfamily, sharing the typical seven-transmembrane domain architecture common to this group[1][3]. However, in humans and some other species, GPR33 is classified as a pseudogene, meaning it is a non-functional gene that does not produce an active protein product. As such, it does not function as a therapeutic target nor is it involved in physiological GPCR-mediated processes in humans. There are no known approved or experimental drugs or ligands that interact with GPR33, nor are there validated roles as a disease biomarker or in therapy monitoring. It is sometimes discussed in the context of evolutionary genomic studies due to its pseudogenization in humans, but it does not represent a viable molecular target for pharmacological intervention. Notes and context: GPR33 was originally annotated as a receptor, but subsequent research has established that it is a pseudogene in humans, lacking a functional open reading frame and therefore not encoding a working receptor protein. As a member of the GPCR family, if GPR33 were functional, it would be expected to play a role in signal transduction, as does the rest of the family [1][3], but this is not the case in humans due to its pseudogene status. There are no documented interacting drugs, documented clinical biomarkers, or safety/therapeutic challenges related to GPR33 because it is not expressed as a functional protein in humans. Summary: GPR33 does not constitute an active therapeutic target in humans due to its characterization as a pseudogene; no pharmacological or clinical information is associated with it. Thus, is_target = false and is_incorrect = true (the target is not therapeutically relevant in humans, though the naming and pseudogene status may cause confusion).

Other names
GPR33G protein-coupled receptor 33probable G-protein coupled receptor 33G protein-coupled receptor 33 pseudogene
02

Biological functions

Signal transduction (general GPCR function[1][3])

Beyond the preview

Go deeper on Probable G protein-coupled receptor 33 (GPR33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probable G protein-coupled receptor 33 (GPR33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call